U-GEMMs

Spontaneous Tumor

Spontaneous mouse models are experimental mice that develop tumors due to the abnormal manifestation caused by genetic mutations. 

Mice
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(CAG-LSL-NFE2L2(G81S)-IRES-Luciferase-2A-tdTomato)Smoc
Strain State:Embryo cryopreservation | Cat. NO.:NM-KI-190077
Research Application:cancer research
Mice
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(CAG-LSL-PIK3CA(H1047R)-IRES-luciferase-2A-tdTomato)Smoc
Strain State:Repository Live | Cat. NO.:NM-KI-190065
Disease Connection:breast cancer, CLOVES syndrome, ovarian cancer, brain glioma
Mice
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem(CAG-LSL-SOX2-IRES-Luciferase-2a-EGFP-WPRE-polyA)Krasem4(LSL-G12D)Smoc
Strain State:Repository Live | Cat. NO.:NM-KI-234153
Mice
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(SA-Frt-2xpolyA-CAG-Frt-LSL-TM6SF2-IRES-GFP-WPRE-PA)Smoc
Strain State:Embryo cryopreservation | Cat. NO.:NM-KI-200017
Research Application:Non-alcoholic fatty liver disease
Mice
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem(SA-polyA-CAG-LSL-TPM3-NTRK1-IRES-luc-2A-tdTomato-WPRE-polyA)Smoc
Strain State:Repository Live | Cat. NO.:NM-KI-190098
Research Application:Colorectal carcinoma related.
Mice
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(CAG-FRT-LSL-Kras(G12C)-IRES-Luciferase-polyA)Smoc
Strain State:Repository Live | Cat. NO.:NM-KI-200323
Mice
Strain Name:BALB/cAnSmoc-Gt(ROSA)26Sorem2(CAG-FRT-LSL-Kras(G12C)-IRES-Luciferase-polyA)Smoc
Strain State:Repository Live | Cat. NO.:NM-KI-200324
Mice
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(CAG-LSL-Luciferase-2A-EGFP-wpre-polyA)Trp53tm2(flox)Krasem4(LSL-G12D)Smoc
Strain State:Developing | Cat. NO.:NM-KI-234519
Mice
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(SA-LSL-Notch1C-IRES-nEGFP)Smoc
Strain State:Embryo cryopreservation | Cat. NO.:NM-KI-200036
Research Application:Spontaneous tumor model
Mice
Strain Name:C57BL/6Smoc-Gt(ROSA)26Sorem1(SA-loxp-stop-loxp-SmoM2(W539L)-IRES-tdTomato-WPRE-polyA)Smoc
Strain State:Embryo cryopreservation | Cat. NO.:NM-KI-200035
Research Application:Medulloblastoma
Email Back to top